Several evolving themes: allelic state & LOH, disease heterogeneity, transplant, immune biology &emerging therapeutic vulnerabilities.
Also excited to share our work on #PPM1D, #DDX41, and a better prognostic TP53 subset from the #COMMAND_consortium.
Several evolving themes: allelic state & LOH, disease heterogeneity, transplant, immune biology &emerging therapeutic vulnerabilities.
Also excited to share our work on #PPM1D, #DDX41, and a better prognostic TP53 subset from the #COMMAND_consortium.
🧪
🧪
#bioinformatics #cancergenomics
#bioinformatics #cancergenomics
J Clin Oncol · 4 Nov 2026
doi.org/10.1200/JCO-26-00280
J Clin Oncol · 4 Nov 2026
doi.org/10.1200/JCO-26-00280
🎗️ 犬猫 腫瘍ニュース — 2026.11.12 犬猫の腫瘍・がん関連ニュース&論文 計7件 🎗️ 腫瘍・がん関連ニュース — 2026.11.12 本日 7件 1. 🧬 研究・科学 バーニーズ・マウンテン・ドッグのリンパ腫27検体の遺伝子変異を初めて解析——96.3%に体細胞変異、最多はTRAF3の25.9%、EP300の変異22%は犬種特有の可能性(ミシガン州立大学の検体バンクほか、Veterinary Oncology) 📅 2026.11.05…
🎗️ 犬猫 腫瘍ニュース — 2026.11.12 犬猫の腫瘍・がん関連ニュース&論文 計7件 🎗️ 腫瘍・がん関連ニュース — 2026.11.12 本日 7件 1. 🧬 研究・科学 バーニーズ・マウンテン・ドッグのリンパ腫27検体の遺伝子変異を初めて解析——96.3%に体細胞変異、最多はTRAF3の25.9%、EP300の変異22%は犬種特有の可能性(ミシガン州立大学の検体バンクほか、Veterinary Oncology) 📅 2026.11.05…
->Nature | More on "Mutant p53 targeting in cancer" at BigEarthData.ai
In mouse tumor models, activating Cas12a2 by a target transcript enables RNA-triggered chromatin shredding that selectively eliminates cells with mutations in TP53, MYC, and other hard-to-drug cancer genes.
doi.org/10.1158/2159-8290.cd-nw2026-0072
In mouse tumor models, activating Cas12a2 by a target transcript enables RNA-triggered chromatin shredding that selectively eliminates cells with mutations in TP53, MYC, and other hard-to-drug cancer genes.
doi.org/10.1158/2159-8290.cd-nw2026-0072
@ajhgnews.bsky.social
👇 Link to the full episode in the first reply.
@ajhgnews.bsky.social
👇 Link to the full episode in the first reply.
📄Deep #CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome
📄Deep #CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome
Interested in a PhD?- are you a medical student? TP53-mutant acute erythroid leukaemia is among the most difficult cancers to treat and may rely on surrounding cells for survival.
Interested in a PhD?- are you a medical student? TP53-mutant acute erythroid leukaemia is among the most difficult cancers to treat and may rely on surrounding cells for survival.